about
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesDefining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.
P50
name
Sebastien Rinaldetti
@ast
Sebastien Rinaldetti
@en
Sebastien Rinaldetti
@nl
type
label
Sebastien Rinaldetti
@ast
Sebastien Rinaldetti
@en
Sebastien Rinaldetti
@nl
prefLabel
Sebastien Rinaldetti
@ast
Sebastien Rinaldetti
@en
Sebastien Rinaldetti
@nl